Results 11 to 20 of about 19,127 (154)

Trimethylamine N-oxide in atrial fibrillation progression

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2020
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases.
Petra Büttner   +7 more
doaj   +3 more sources

Role of Trimethylamine N-Oxide in Heart Failure

open access: yesReviews in Cardiovascular Medicine
Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the ...
Lele Jing   +6 more
doaj   +3 more sources

Trimethylamine N-Oxide: The Good, the Bad and the Unknown [PDF]

open access: yesToxins, 2016
Trimethylamine N-oxide (TMAO) is a small colorless amine oxide generated from choline, betaine, and carnitine by gut microbial metabolism. It accumulates in the tissue of marine animals in high concentrations and protects against the protein ...
Manuel T. Velasquez   +3 more
doaj   +3 more sources

Trimethylamine-N-oxide and cerebral stroke risk: A review

open access: yesNeurobiology of Disease
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced by the action of gut microbiota and the hepatic enzyme Flavin Mono‑oxygenase 3 (FMO3).
Phurbu Dolkar   +13 more
doaj   +3 more sources

The microbial metabolite trimethylamine N-oxide and the kidney diseases

open access: yesFrontiers in Cellular and Infection Microbiology
Trimethylamine N-oxide (TMAO), a metabolite, is a co-metabolite produced by both gut microbiota and livers, originating from foods rich in choline or carnitine.
Jin-Qi Su   +15 more
doaj   +3 more sources

Trimethylamine-N-Oxide

open access: yesJACC: Basic to Translational Science, 2021
[Figure: see text]
Adel, Fadi W., Chen, Horng H.
openaire   +2 more sources

Trimethylamine N-oxide in cardiovascular disease

open access: yesAdvances in Clinical and Experimental Medicine, 2022
Although traditional cardiovascular risk factors are well established and understood, mortality and morbidity in patients with cardiovascular disease (CVD) remains high. Exploring new pathophysiological pathways enables a better understanding of CVD at both the molecular and clinical levels.
Radoslaw Konieczny, Wiktor Kuliczkowski
openaire   +2 more sources

Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Trimethylamine‐N‐oxide (TMAO) is a small molecule derived from the metabolism of dietary nutrients by gut microbes and contributes to cardiovascular disease. Plasma TMAO increases following consumption of red meat.
Marc Ferrell   +11 more
doaj   +1 more source

Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide

open access: yesMicrobiome, 2021
Background Communication between the gut microbiota and the brain is primarily mediated via soluble microbe-derived metabolites, but the details of this pathway remain poorly defined. Methylamines produced by microbial metabolism of dietary choline and l-
Lesley Hoyles   +13 more
doaj   +1 more source

Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide [PDF]

open access: yesJournal of Stroke, 2019
Trimethylamine N-oxide (TMAO) is produced when trimethylamine, a waste product of gut microbes, is converted via hepatic flavin monooxygenases. As TMAO is a potential causative factor in various cardiovascular diseases (CVDs) considerable research ...
Hyo Suk Nam
doaj   +1 more source

Home - About - Disclaimer - Privacy